4//SEC Filing
PAUL AMY S 4
Accession 0001235802-19-000026
CIK 0001492658other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:43 PM ET
Size
9.6 KB
Accession
0001235802-19-000026
Insider Transaction Report
Form 4
PAUL AMY S
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2019-03-07−10,309→ 0 totalExercise: $15.01Exp: 2019-05-13→ Ordinary Shares (10,309 underlying) - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2019-03-07$15.01/sh+10,309$154,738→ 55,992 total - Sale
Ordinary Shares, par value EUR 0.03 per share
2019-03-07$31.52/sh−10,309$324,965→ 45,683 total
Footnotes (5)
- [F1]The reporting person exercised this option because the option was in the money and scheduled to expire on May 13, 2019.
- [F2]Total holdings were increased by one ordinary share due to a rounding error in the Form 4 report that was filed with the SEC on July 26, 2018.
- [F3]Includes 5,306 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.51 to $31.55, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- [F5]This option has fully vested.
Documents
Issuer
Wright Medical Group N.V.
CIK 0001492658
Entity typeother
Related Parties
1- filerCIK 0001235355
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:43 PM ET
- Size
- 9.6 KB